• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SIRT6 和 SIRT7 作为头颈部鳞状细胞癌循环标志物的潜力。

The potential of SIRT6 and SIRT7 as circulating markers for head and neck squamous cell carcinoma.

机构信息

Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung City, Taiwan, R.O.C.

Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung City, Taiwan, R.O.C. Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan, R.O.C.

出版信息

Anticancer Res. 2014 Dec;34(12):7137-43.

PMID:25503141
Abstract

BACKGROUND

We have previously demonstrated altered SIRT gene family in head and neck squamous cell carcinoma (HNSCC). In the present study we aimed to investigate whether the SIRT gene family was also altered in peripheral blood (PB) of patients with HNSCC and the possibility to be used as circulating biomarkers.

PATIENTS AND METHODS

The expression profiles of the 7 SIRT genes of PB leukocytes from 34 patients with HNSCC before and after surgery and 31 healthy individuals were investigated.

RESULTS

In the cancer group, the expression level of SIRT1 was down-regulated (p<0.05); in contrast, SIRT6 and SIRT7 were significantly up-regulated (p<0.001). Patients with advanced-stage HNSCC had lower expression of SIRT1 and SIRT3. Recovery of SIRT6 and SIRT7 was observed in postoperative patients (p<0.005).

CONCLUSION

SIRT genes were altered in PB leukocytes of HNSCC patients and SIRT6 and SIRT7 are potential circulating prognostic markers for HNSCC.

摘要

背景

我们之前已经证明头颈部鳞状细胞癌(HNSCC)中 SIRT 基因家族发生改变。在本研究中,我们旨在研究 SIRT 基因家族是否也在 HNSCC 患者的外周血(PB)中发生改变,并探讨其作为循环生物标志物的可能性。

患者和方法

检测了 34 例 HNSCC 患者手术前后 PB 白细胞中 7 个 SIRT 基因的表达谱,并与 31 名健康个体进行比较。

结果

在癌症组中,SIRT1 的表达水平下调(p<0.05);相反,SIRT6 和 SIRT7 则显著上调(p<0.001)。晚期 HNSCC 患者的 SIRT1 和 SIRT3 表达水平较低。术后患者 SIRT6 和 SIRT7 的表达水平恢复(p<0.005)。

结论

HNSCC 患者 PB 白细胞中的 SIRT 基因发生改变,SIRT6 和 SIRT7 是 HNSCC 潜在的循环预后标志物。

相似文献

1
The potential of SIRT6 and SIRT7 as circulating markers for head and neck squamous cell carcinoma.SIRT6 和 SIRT7 作为头颈部鳞状细胞癌循环标志物的潜力。
Anticancer Res. 2014 Dec;34(12):7137-43.
2
Altered expression of SIRT gene family in head and neck squamous cell carcinoma.SIRT基因家族在头颈部鳞状细胞癌中的表达改变。
Tumour Biol. 2013 Jun;34(3):1847-54. doi: 10.1007/s13277-013-0726-y. Epub 2013 Mar 12.
3
PER1 and CLOCK: potential circulating biomarkers for head and neck squamous cell carcinoma.PER1和生物钟基因:头颈部鳞状细胞癌潜在的循环生物标志物
Head Neck. 2014 Jul;36(7):1018-26. doi: 10.1002/hed.23402. Epub 2013 Sep 12.
4
Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma.循环微小RNA作为头颈部鳞状细胞癌的新型预后生物标志物
Cancer Biol Ther. 2015;16(7):1042-6. doi: 10.1080/15384047.2015.1045692. Epub 2015 May 7.
5
Single-Cell Molecular Profiling of Head and Neck Squamous Cell Carcinoma Reveals Five Dysregulated Signaling Pathways Associated With Circulating Tumor Cells.头颈部鳞状细胞癌的单细胞分子剖析揭示了与循环肿瘤细胞相关的五条失调信号通路。
Cancer Control. 2024 Jan-Dec;31:10732748241251571. doi: 10.1177/10732748241251571.
6
Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC).头颈部鳞状细胞癌(HNSCC)患者循环肿瘤细胞亚群的检测。
PLoS One. 2014 Dec 5;9(12):e113706. doi: 10.1371/journal.pone.0113706. eCollection 2014.
7
Gene expression patterns of Sirtuin family members (SIRT1 TO SIRT7): Insights into pathogenesis and prognostic of Myelodysplastic neoplasm.Sirtuin 家族成员(SIRT1 至 SIRT7)的基因表达模式:对骨髓增生异常肿瘤发病机制和预后的深入了解。
Gene. 2024 Jul 15;915:148428. doi: 10.1016/j.gene.2024.148428. Epub 2024 Apr 3.
8
Association of SIRT1 and tumor suppressor gene TAp63 expression in head and neck squamous cell carcinoma.SIRT1与肿瘤抑制基因TAp63在头颈部鳞状细胞癌中的表达相关性
Tumour Biol. 2015 Sep;36(10):7865-72. doi: 10.1007/s13277-015-3515-y. Epub 2015 May 7.
9
Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.对头颈鳞状细胞癌进行全面基因组分析,揭示 FGFR1 扩增和肿瘤基因组改变负担可作为生存预后的生物标志物。
Eur J Cancer. 2018 Mar;91:47-55. doi: 10.1016/j.ejca.2017.12.016. Epub 2018 Jan 11.
10
Loss of Mitochondrial Tumor Suppressor Genes Expression Is Associated with Unfavorable Clinical Outcome in Head and Neck Squamous Cell Carcinoma: Data from Retrospective Study.线粒体肿瘤抑制基因表达缺失与头颈部鳞状细胞癌不良临床预后相关:一项回顾性研究的数据
PLoS One. 2016 Jan 19;11(1):e0146948. doi: 10.1371/journal.pone.0146948. eCollection 2016.

引用本文的文献

1
Loss of Sirtuin 7 impairs cell motility and proliferation and enhances S-phase cell arrest after 5-fluorouracil treatment in head and neck cancer.沉默调节蛋白7的缺失会损害细胞的运动性和增殖能力,并增强头颈部癌在接受5-氟尿嘧啶治疗后的S期细胞阻滞。
Sci Rep. 2025 Jan 16;15(1):2123. doi: 10.1038/s41598-024-83349-9.
2
Targeting histone deacetylases in head and neck squamous cell carcinoma: molecular mechanisms and therapeutic targets.靶向头颈部鳞状细胞癌中的组蛋白去乙酰化酶:分子机制和治疗靶点。
J Transl Med. 2024 May 3;22(1):418. doi: 10.1186/s12967-024-05169-9.
3
Discovery of a potent and highly selective inhibitor of SIRT6 against pancreatic cancer metastasis .
发现一种针对胰腺癌转移的强效且高度选择性的SIRT6抑制剂。
Acta Pharm Sin B. 2024 Mar;14(3):1302-1316. doi: 10.1016/j.apsb.2023.11.014. Epub 2023 Nov 10.
4
Immunoexpression of SIRT1, 6, and 7 in oral leukoplakia and oral squamous cell carcinoma.SIRT1、6、7 在口腔白斑病和口腔鳞状细胞癌中的免疫表达。
Odontology. 2024 Jan;112(1):221-229. doi: 10.1007/s10266-023-00816-x. Epub 2023 May 16.
5
Implications of altered sirtuins in metabolic regulation and oral cancer.沉默信息调节因子在代谢调控和口腔癌中的作用。
PeerJ. 2023 Feb 14;11:e14752. doi: 10.7717/peerj.14752. eCollection 2023.
6
The Two-Faced Role of SIRT6 in Cancer.SIRT6在癌症中的双面角色。
Cancers (Basel). 2021 Mar 8;13(5):1156. doi: 10.3390/cancers13051156.
7
MDL-800, an allosteric activator of SIRT6, suppresses proliferation and enhances EGFR-TKIs therapy in non-small cell lung cancer.MDL-800,一种 SIRT6 的别构激活剂,抑制非小细胞肺癌的增殖并增强 EGFR-TKIs 治疗效果。
Acta Pharmacol Sin. 2021 Jan;42(1):120-131. doi: 10.1038/s41401-020-0442-2. Epub 2020 Jun 15.
8
Small-molecule activating SIRT6 elicits therapeutic effects and synergistically promotes anti-tumor activity of vitamin D in colorectal cancer.小分子激活 SIRT6 可发挥治疗作用,并协同促进维生素 D 在结直肠癌中的抗肿瘤活性。
Theranostics. 2020 Apr 27;10(13):5845-5864. doi: 10.7150/thno.44043. eCollection 2020.
9
Impact of Nutrition on Short-Term Exercise-Induced Sirtuin Regulation: Vegans Differ from Omnivores and Lacto-Ovo Vegetarians.营养对短期运动诱导的沉默调节蛋白调节的影响:纯素者与杂食者和乳蛋素食者不同。
Nutrients. 2020 Apr 5;12(4):1004. doi: 10.3390/nu12041004.
10
miR-34a inhibits tumorigenesis of NSCLC via targeting SIRT6.微小RNA-34a通过靶向沉默调节蛋白6抑制非小细胞肺癌的肿瘤发生。
Int J Clin Exp Pathol. 2018 Mar 1;11(3):1135-1145. eCollection 2018.